Literature DB >> 25346852

Spinal and sacroiliac gouty arthritis: report of a case and review of the literature.

Fabiano Nassar Cardoso1, Patrick Omoumi2, Gregoire Wieers3, Baudouin Maldague2, Jacques Malghem2, Frédéric E Lecouvet2, Bruno C Vande Berg2.   

Abstract

In this case report, we describe an "uncommon" case of axial gouty arthropathy in a 69-year-old woman with bilateral sciatica that was thoroughly evaluated with conventional radiography, CT scan, magnetic resonance imaging, bone scintigraphy, and PET-CT. Axial gouty arthropathy should be included in the differential diagnosis of chronic low back pain, mainly when several risk factors for gout are present.

Entities:  

Keywords:  CT scan; MRI; PET-CT; Spine; bone scintigraphy; gouty arthropathy; radiography; sacroiliac

Year:  2014        PMID: 25346852      PMCID: PMC4207284          DOI: 10.1177/2047981614549269

Source DB:  PubMed          Journal:  Acta Radiol Short Rep        ISSN: 2047-9816


Introduction

Gout is a metabolic disorder and the most common form of microcrystalline arthropathy (1). Gouty arthritis is usually monoarticular, more frequently found in men, and usually affects peripheral joints (1). Although axial involvement of gout is generally considered to be rare or unusual (2 –6), recent publications, mostly in the rheumatologic literature, have pointed out that axial gouty arthropathy may be, in fact, much more common than initially perceived (6 –9). With that in mind, we report an “uncommon” case of a 69-year-old woman, with spinal and sacroiliac involvement of gout, thoroughly evaluated with conventional radiography, computed tomography (CT) scan, magnetic resonance imaging (MRI), bone scintigraphy, and PET-CT.

Case report

A 69-year-old obese woman (BMI: 40) with previous history of constrictive pericarditis, chronic renal insufficiency, high blood pressure, and diabetes mellitus was sent by her family physician to the urgent care department of our institution due to low fever and exacerbation of her chronic back pain, uncontrolled with non-steroidal anti-inflammatory drugs (NSAIDs) and tramadol. She suffered from low back pain irradiating to the buttocks and hips, preventing her to bear weight and walk. Her physical examination did not show any motor or sensitive deficits, but sacroiliac provocative tests were positive. She did not have any other articular symptoms or signs. Her medical treatment included daily doses of lisinopril, sinvastatine, carvedilol, acetylsalicylic acid, and furosemide. Laboratory tests found a moderate renal insufficiency with a creatinine clearance of 43 mL/min/1.73 m2 (normal >90 mL/min.1.73 m2); a discrete neutrophilic leukocytosis (10.350 /µL); CRP, 22.5 mg/dl (normal <1.0 mg/dl); total seric calcium, 10.01 mg/dl (normal, 8.80–10.40 mg/dl); alkaline phosphatase, 192 UI/L (normal, 30–120 UI/L); and uric acid, 13.2 mg/dl (normal, 2.7–7.7 mg/dl). Clinically, she was diagnosed with bilateral sciatic and had a history of lumbar vertebral canal stenosis. Bone scan showed increased uptake of both SI joints (Fig. 1a), left L4/L5 interapophyseal joint, symphysis pubis (Fig. 1b), and first metatarsophalangeal joints (Fig. 1c).
Fig. 1.

Bone scan shows strong radiophamaceutical uptake (black arrows) in both sacroiliac joints (a), and less intense in the symphysis pubis (b), and first metatarsophalangeal joints (c).

Bone scan shows strong radiophamaceutical uptake (black arrows) in both sacroiliac joints (a), and less intense in the symphysis pubis (b), and first metatarsophalangeal joints (c). PET-CT also showed increased FDG uptake in the same areas (Fig. 2), and conventional radiography presented typical intra-articular and para-articular “punch-out” bone erosions, well delimited by discrete sclerosis on the SI joints (Fig. 3a), symphysis pubis (Fig. 3b), and fifth proximal interphalangeal joint of the left foot.
Fig. 2.

Coronal PET-CT fusion reformats of the pelvis showing increased 18F-FDG uptake in the symphysis pubis (arrow; (a)), both sacroiliac joints and left L4–L5 interapophyseal joints (arrows; (b)).

Fig. 3.

(a) Radiograph of pelvis (incidence of Ferguson) showing well-defined subchondral bone erosions on both sacroiliac joints (arrows), with discrete adjacent sclerosis. (b) Localized antero-posterior radiography of the symphysis pubis showing similar “punched-out” subchondral (white arrow) and para-articular erosions (black arrow) typically seen on gouty arthropathy.

Coronal PET-CT fusion reformats of the pelvis showing increased 18F-FDG uptake in the symphysis pubis (arrow; (a)), both sacroiliac joints and left L4–L5 interapophyseal joints (arrows; (b)). (a) Radiograph of pelvis (incidence of Ferguson) showing well-defined subchondral bone erosions on both sacroiliac joints (arrows), with discrete adjacent sclerosis. (b) Localized antero-posterior radiography of the symphysis pubis showing similar “punched-out” subchondral (white arrow) and para-articular erosions (black arrow) typically seen on gouty arthropathy. MRI of the SI joints displayed bony erosions filled with a discrete material of intermediate-low signal intensity on T1-weighted (T1W) sequences (Fig. 4a), intermediate signal intensity on T2-weighted (T2W) images (Fig. 4b), and avid enhancement after intravenous gadolinium injection (Fig. 4c). Only a little amount of fluid was found within the articular spaces, and adjacent bone marrow edema was identified on T2W fat-saturated sequences (Fig. 4b).
Fig. 4.

Axial MR T1W (a), T2W (b) and T1 contrast-enhanced fat-suppressed (c) images through the sacroiliac joints, exhibiting bilateral bone erosions (white arrows), intra-articular fluid (dashed arrows), and enhancement after gadolinium injection (open arrow).

Axial MR T1W (a), T2W (b) and T1 contrast-enhanced fat-suppressed (c) images through the sacroiliac joints, exhibiting bilateral bone erosions (white arrows), intra-articular fluid (dashed arrows), and enhancement after gadolinium injection (open arrow). Besides the initial diagnosis of spinal canal stenosis, para-articular bone erosions with thin sclerotic margins were identified on the left interapophyseal facets of L4/L5 (Fig. 5a) and in both SI joints (Fig. 5b), and a high density material was found within these bony lesions, with a mean density of 106 HU (Fig. 5c).
Fig. 5.

Axial CT scan on bone windows showing subchondral and para-articular bone erosions on the left L4–L5 interapophyseal joint (circle on (a)) and both sacroiliac joints (arrows on (b)). Small region of interest disclosing the high density material (102 HU) within one of these bone erosions on the left interapophyseal joint (c).

Axial CT scan on bone windows showing subchondral and para-articular bone erosions on the left L4–L5 interapophyseal joint (circle on (a)) and both sacroiliac joints (arrows on (b)). Small region of interest disclosing the high density material (102 HU) within one of these bone erosions on the left interapophyseal joint (c). After thorough evaluation of these exams, a radiologic diagnosis of gouty arthritis with axial involvement was made, and as a differential diagnosis, amyloidosis associated with secondary hyperparathyroidism, which was further discarded since she did not present any other findings compatible with these disorders. Nevertheless, since she did not present clinical findings consistent with peripheral microcrystalline arthropathy, a CT-guided sacro-iliac biopsy was performed (Fig. 6) to exclude septic arthritis due to an indolent pathogen, such as brucella or mycobacteria. The aspiration revealed a white chalky material that exhibited negatively birefringent monourate sodium crystals under polarized light microscopy.
Fig. 6.

CT-guided biopsy needle placed on the left sacroiliac joint revealing a white chalky material with negatively birefringent monourate sodium crystals under polarized light macroscopy (not shown).

CT-guided biopsy needle placed on the left sacroiliac joint revealing a white chalky material with negatively birefringent monourate sodium crystals under polarized light macroscopy (not shown). She was treated with colchicine, clinically improved from her back pain, and after 15 days of treatment her CRP and uric acid levels dropped from 22.5 mg/dl and 13.2 mg/dl, to 0.4 mg/dl and 9.9 mg/dl, respectively. The patient was eventually discharged and her dose of colchicine interrupted, maintaining a daily allopurinol intake.

Discussion

Gout results from the deposition of uric acid salts and crystals in and around the joints and soft tissues (1). It affects 3.9% of the total North-American adult population (10), with a peak age incidence occurring between 30 and 50 years, being 5 times more common in men than premenopausal women. After the age of 60 years, the prevalence of the disease in women tends to approach that seen in men (1). The first attack of gouty arthritis is monoarticular in about 85–90% of cases, with the first metatarsophalangeal joint being affected in over 50% of patients (11). It is more frequently seen in the appendicular skeleton, mainly in the lower limbs, despite the fact that with chronic disease, any joint in the body may be affected (1). There are also several risk factors associated with hyperuricemia, such as obesity, hypertension, cardiomyopathy, chronic renal failure, and intake of diuretics and salicylates in low doses (12), all of which our patient had. In the acute phase, conventional radiography can demonstrate soft tissue swelling and joint effusion. During the chronic phase, or tophaceous gout, which is characterized by the presence of deposits of monosodium urate (tophus), well-defined intra-articular or para-articular erosions delimited by thin sclerotic borders can be identified. Another characteristic feature is the presence of an “overhanging edge”, a thin bony expansion at the periphery of the erosion protruding into the soft tissues and partially covering the tophus (11). The joint space is remarkably well preserved until late in the disease, and there is no periarticular osteopenia, although with progression of the arthropathy, disuse osteoporosis may be seen (11). CT scan is more useful to evaluate the spine and sacroiliac joints than X-rays, and can also be used to measure tophi density, which present an attenuation of 160–170 HU. Recently, dual-energy CT was shown to detect urate deposits with an overall accuracy that was in the range of 87–94% (13). Radiographic analyses have shown a prevalence of sacroiliac gouty arthropathy in the range of 13–17% (1,7), with a recent publication showing that axial involvement in gout could be as high as 35% with CT scan evaluation (8), although a bias of patient selection could, at least in part, explain these results. The tophus has iso- to low signal intensity on T1W images in relation to muscle, but it is quite variable on T2W images, due to differences in calcium concentration within a tophus (14). The differentiation of gouty arthritis from infectious arthritis or osteomyelitis is not always easy. As recently described in the literature, the bone marrow edema pattern is usually mild with uncomplicated gout, compared to cases with concomitant osteomyelitis (15). However, sometimes it can be troublesome to differentiate the two diagnoses, since we identified extensive bone marrow edema in T2W fat-saturated images. Furthermore, there is increased radiopharmaceutical uptake in gouty arthritis when assessed with bone scan, as seen in any inflammatory condition, making it very difficult to differentiate from osteomyelitis (16). To our knowledge, this is the first report to evaluate gouty arthritis with FDG PET-CT, although tophaceous gout has already been described with conventional FDG-PET (17 –19), unveiling the hypermetabolic activity in and around the joints in these patients. Nevertheless, it is imperative to clarify, that this is costly and involves unnecessary radiation levels. However, it was ordered in our patient evaluation, since the attending physician did not agree with our first diagnosis of gouty arthropathy, making the awareness of less common joints affection by gout important not only to radiologist, but also to clinicians. In conclusion, despite spinal and sacroiliac gouty arthritis is considered to be unusual, or rare, radiologists should take into account this possibility, especially when associated to other risk factors, such as obesity, hypertension, cardiomyopathy, chronic renal failure, or intake of diuretics and salicylates.
  19 in total

Review 1.  The management of hyperuricemia and gout in patients with heart failure.

Authors:  Lukas E Spieker; Frank T Ruschitzka; Thomas F Lüscher; Georg Noll
Journal:  Eur J Heart Fail       Date:  2002-08       Impact factor: 15.534

Review 2.  Imaging in gout: insights into the pathological features of disease.

Authors:  Nicola Dalbeth; Anthony Doyle; Fiona M McQueen
Journal:  Curr Opin Rheumatol       Date:  2012-03       Impact factor: 5.006

Review 3.  Axial (spinal) gout.

Authors:  Elena Lumezanu; Rukmini Konatalapalli; Arthur Weinstein
Journal:  Curr Rheumatol Rep       Date:  2012-04       Impact factor: 4.592

4.  Widespread tophaceous gout demonstrating avid F-18 fluorodeoxyglucose uptake.

Authors:  Michael Steiner; Vani Vijayakumar
Journal:  Clin Nucl Med       Date:  2009-07       Impact factor: 7.794

5.  MR imaging of tophaceous gout.

Authors:  J S Yu; C Chung; M Recht; T Dailiana; R Jurdi
Journal:  AJR Am J Roentgenol       Date:  1997-02       Impact factor: 3.959

6.  Tophaceous gout causing atlanto-axial subluxation mimicking rheumatoid arthritis: a case report.

Authors:  N N Wazir; V Moorthy; A Amalourde; H H Lim
Journal:  J Orthop Surg (Hong Kong)       Date:  2005-08       Impact factor: 1.118

7.  Magnetic resonance imaging bone edema is not a major feature of gout unless there is concomitant osteomyelitis: 10-year findings from a high-prevalence population.

Authors:  Yih Jia Poh; Nicola Dalbeth; Anthony Doyle; Fiona M McQueen
Journal:  J Rheumatol       Date:  2011-10-01       Impact factor: 4.666

Review 8.  Advanced imaging of gout.

Authors:  Amilcare Gentili
Journal:  Semin Musculoskelet Radiol       Date:  2003-09       Impact factor: 1.777

9.  Cutaneous and subcutaneous imaging on FDG-PET: benign and malignant findings.

Authors:  Steven L Blumer; Luke R Scalcione; Bobbi N Ring; Ravi Johnson; Betty Motroni; Douglas S Katz; Elizabeth Y Yung
Journal:  Clin Nucl Med       Date:  2009-10       Impact factor: 7.794

Review 10.  Gout: a clinical and radiologic review.

Authors:  Johnny U V Monu; Thomas L Pope
Journal:  Radiol Clin North Am       Date:  2004-01       Impact factor: 2.303

View more
  8 in total

Review 1.  Lower back pain as a manifestation of acute gouty sacroiliitis: Utilization of dual-energy computed tomography (DECT) in establishing a diagnosis.

Authors:  Rajaie Namas; Safa Botros Hegazin; Esat Memişoğlu; Abhay Joshi
Journal:  Eur J Rheumatol       Date:  2019-09-05

2.  99mTc-methylene diphosphonate SPECT/CT imaging of gout spondylitis: a case report.

Authors:  Yan Wang; Yan Zha; Rongfeng She; Gaofeng Sun; Shuang Li; Lin Liu; Neil Roberts; Yaying Li
Journal:  J Int Med Res       Date:  2022-10       Impact factor: 1.573

Review 3.  Gout in the Spine: Imaging, Diagnosis, and Outcomes.

Authors:  Michael Toprover; Svetlana Krasnokutsky; Michael H Pillinger
Journal:  Curr Rheumatol Rep       Date:  2015-12       Impact factor: 4.592

4.  Utility of CT imaging in differentiating sacroiliitis associated with spondyloarthritis from gouty sacroiliitis: a retrospective study.

Authors:  Jyoti Panwar; Pulukool Sandhya; Madhavi Kandagaddala; Aswin Nair; Visalakshi Jeyaseelan; Debashish Danda
Journal:  Clin Rheumatol       Date:  2017-11-08       Impact factor: 2.980

5.  Gouty arthritis of the spine in a renal transplant patient: a clinical case report: an unusual presentation of a common disorder.

Authors:  Sofie Dhaese; Marijke Stryckers; Hans Van Der Meersch; Wim Terryn; Steven Van Laecke
Journal:  Medicine (Baltimore)       Date:  2015-04       Impact factor: 1.889

6.  Spinal gout: A review with case illustration.

Authors:  Hossein Elgafy; Xiaochen Liu; Joseph Herron
Journal:  World J Orthop       Date:  2016-11-18

7.  Evaluation of Intra-articular Corticosteroid Injections in Patients with Sacroiliac Pain.

Authors:  Ali Andalib; Mohammadreza Etemadifar; Mohammad Ansari Bardei
Journal:  Adv Biomed Res       Date:  2022-02-28

8.  Spinal Cord Compression Due to Tophaceous Vertebral Gout: A Case Report.

Authors:  Duniel Abreu Casas; Orestes R López-Piloto; Norbery J Rodríguez de la Paz; José M Plasencia-Leonardo; Daniel Íñiguez-Avendaño; Joel V Gutierrez
Journal:  Cureus       Date:  2022-07-21
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.